Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
Taylor AL, Ziesche S, Yancy C, Carson P, D'Agostino R Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Taylor AL, et al. Among authors: taylor m. N Engl J Med. 2004 Nov 11;351(20):2049-57. doi: 10.1056/NEJMoa042934. Epub 2004 Nov 8. N Engl J Med. 2004. PMID: 15533851 Free article. Clinical Trial.
Outcomes by gender in the African-American Heart Failure Trial.
Taylor AL, Lindenfeld J, Ziesche S, Walsh MN, Mitchell JE, Adams K, Tam SW, Ofili E, Sabolinski ML, Worcel M, Cohn JN; A-HeFT Investigators. Taylor AL, et al. J Am Coll Cardiol. 2006 Dec 5;48(11):2263-7. doi: 10.1016/j.jacc.2006.06.020. Epub 2006 Nov 9. J Am Coll Cardiol. 2006. PMID: 17161257 Free article.
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial.
Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN. Anand IS, et al. Among authors: taylor al. J Am Coll Cardiol. 2007 Jan 2;49(1):32-9. doi: 10.1016/j.jacc.2006.04.109. Epub 2006 Dec 14. J Am Coll Cardiol. 2007. PMID: 17207719 Free article.
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN; African-American Heart Failure Trial Investigators. Taylor AL, et al. Among authors: taylor m. Circulation. 2007 Apr 3;115(13):1747-53. doi: 10.1161/CIRCULATIONAHA.106.644013. Epub 2007 Mar 19. Circulation. 2007. PMID: 17372175 Clinical Trial.
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators. Ghali JK, et al. Among authors: taylor al. Am J Cardiovasc Drugs. 2007;7(5):373-80. doi: 10.2165/00129784-200707050-00007. Am J Cardiovasc Drugs. 2007. PMID: 18041162 Clinical Trial.
Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
Anand IS, Win S, Rector TS, Cohn JN, Taylor AL. Anand IS, et al. Among authors: taylor al. Circ Heart Fail. 2014 Sep;7(5):759-65. doi: 10.1161/CIRCHEARTFAILURE.114.001360. Epub 2014 Jun 26. Circ Heart Fail. 2014. PMID: 24970468 Clinical Trial.
318 results